Departmental news
Researchers wake-up DNA from soil bacteria to discover novel acid antibiotic
A team led by Dr Christophe Corre (SLS) and Dr Manuela Tosin (Chemistry) have characterised a new bioactive natural product whose derivatives could be used as antibiotics and help fight infections.
Arctic's Global Seed Vault to receive 101 samples from Warwick's Vegetable Genebank
101 seed samples from 18 different types of crop species including onions, carrots and cauliflower are to be deposited at the Svalbard Global Seed Vault in Arctic Norway on the 31 October 2018, from the UK Vegetable Genebank (UKVGB) at the University of Warwick.
UK scientists to join Arctic research ship 'drifting' past North Pole
UK scientists will join what could be the largest-scale Arctic research expedition ever planned when the German research ship RV Polarstern is deliberately lodged into sea ice to drift past the North Pole. Research includes Dr Hendrik Schaefer of the University of Warwick’s School of Life Sciences.
Image courtesy of Alfred Wegener Institute.
Real-time foot-and-mouth strategy to better fight disease
Professor Laura Green moving to University of Birmingham
Congratulations to Deputy Pro-Vice-Chancellor (interdisciplinary research and impact) and former Head of the School of Life Sciences, Professor Laura Green, who has been appointed to the role of Pro-Vice-Chancellor for Life and Environmental Sciences at the University of Birmingham. She will take up her new role on 1 October 2018.
Enzyme discovery could help in fight against TB
An enzyme structure discovery made by scientists at the University of Warwick could help to eradicate tuberculosis (TB).
Research by a team led by Dr Elizabeth Fullam, has revealed new findings about an enzyme found in Mycobacterium tuberculosis (Mtb) the bacterium that causes TB. TB causes more deaths than any other infectious disease, including from HIV and malaria.
Two million pounds awarded to fight disease in East Africa
The University of Warwick has been awarded £2 million to tackle the spread of viruses in East Africa.
The award has been made to the NIHR Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa at the University of Warwick. GeMVi brings together expertise in pathogen sequencing and predicative modelling. Life Sciences academics Professor James Nokes and Professor Matt Keeling are co-investigators.
Dr Dan Smith named as honorary SLS Industry Professor
Dr Smith is currently Chief Scientific Officer at Cobra Biologics Ltd., but he started his scientific career here at Warwick, with a BSc in Biochemistry then a PhD on the mechanism of action at the cellular level of cytotoxic proteins such as ricin.
By becoming an honorary Industrial Professor in our School, Dr. Smith will bring widespread experience in both the workings of a multi-million budget R&D company in a sector at the forefront of biomedical products and also in academic research. His specific expertise in knowledge transfer and experience in developing successful collaborations between regional development agencies, industry and academics will be enormously useful.
Dr Smith will bring many links with industries that we do not yet interact with, both in the UK and internationally. He will contribute ideas and contacts to help our undergraduate students secure industrial placements, a key strategic development area for the School.
Dr Smith will also aid our technology transfer to support start-ups with commercial promise. His past work is highly interdisciplinary in both the academic and industrial sides in chemistry and biology, knowledge of which can massively impact startup success.
We welcome him to the School.
Memory processes depend on protein ‘off-switch’ – could lead to new Alzheimer’s treatments
Memory, learning and cognitive flexibility depend on a protein ‘off-switch’ in the brain, according to a breakthrough discovery made by an international research collaboration co-led by Dr Mark Wall at the University of Warwick.
This new knowledge could enable us to better understand and combat neurological diseases which inhibit memory, such as Alzheimer’s.
Life Sciences gets share of £2.6 million research funding from Diabetes UK
Diabetes UK has committed to invest £2.6 million in 19 brand new projects which aim to make life-changing improvements in diabetes care, and reduce people’s risk of Type 2 diabetes.
The funding will be given to projects looking into Type 1, Type 2 and gestational diabetes.
In one of these projects, Dr Freya Harrison, from the School of Life Sciences, will be using medieval remedies to find new sources of antibiotics. She has already discovered a combination that can kill antibiotic-resistant bacteria in the lab.